Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 90 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1862. Clear
Clear
Q2
LUNDBECK LLC for LUNDBECK LLC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q2
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $30,000.00 income
Health Issues
View → Q2
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income
Medicare/Medicaid
View → Q1
EMD SERONO, INC. for EMD SERONO INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Pharmacy, Veterans, Health Issues, Medicare/Medicaid
View → Q1
TIBER CREEK GROUP for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations
View → Q1
INCYTE CORPORATION for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate
Medicare/Medicaid
View → Q1
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View → Q1
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Copyright/Patent/Trademark, Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs
View → Q1
TIBER CREEK GROUP for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View → Q1
TIBER CREEK GROUP for EMD SERONO, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
TIBER CREEK GROUP for ASTRAZENECA
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View → Q1
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → Q1
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income
Health Issues
View → Q1
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Medicare/Medicaid
View → Q1
LUNDBECK LLC for LUNDBECK LLC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → 4A
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View → Q4
EMD SERONO, INC. for EMD SERONO INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q4
SPLITOAK STRATEGIES LLC for JOHNSON & JOHNSON SERVICES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View → Q4
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View → Q4
SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → Q4
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View → Q4
THE NICKLES GROUP, LLC for MERCK & CO. INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View → Q4
INCYTE CORPORATION for INCYTE CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate
Medicare/Medicaid
View → Q4
TIBER CREEK GROUP for INCYTE CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View → Q4
TIBER CREEK GROUP for EMD SERONO, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Page 1 of 4 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem